Artia Global Partners LP Purchases Shares of 45,000 Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Artia Global Partners LP purchased a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,000 shares of the company’s stock, valued at approximately $5,375,000. Neurocrine Biosciences accounts for approximately […]

Related Keywords

San Diego ,California ,United States ,Williamh Rastetter ,Kevinc Gorman ,Julie Cooke ,Wyliew Vale ,Neurocrine Biosciences ,Exchange Commission ,Neurocrine Biosciences Inc ,Acadian Asset Management ,Hightower Advisors ,Nasdaq ,Rice Hall James Associates ,Financial Services Group Inc ,Canaccord Genuity Group ,Dimensional Fund Advisors ,Neurocrine Biosciences Company Profile ,Citigroup ,Artia Global Partners ,Get Rating ,Hall James ,Tower Advisors ,Services Group ,Asset Management ,Fund Advisors ,Director William ,Neurocrine Biosciences Daily ,